【摘要】 目的:观察经支气管动脉灌注化疗药物治疗肺癌的疗效。材料与方法:对原发性肺癌206例观察血供类型,细胞学分型,病程分期与疗效的关系。结果:多血供型CR+PR89%优于中、少血供型。鳞癌、小细胞肺癌CR+PR为77%和79%于其它细胞型。Ⅱ期和ⅢA期CR+CP为80%和62%优于ⅢB期和Ⅳ期。结论:经支气管动脉灌注化疗药物是治疗肺癌的有效方法,疗效取决于肿瘤血供、细胞组织类型和病程分期。更多还原

【Abstract】 Purpose:To observe the bronchial arterial chemotherapy for lung cancer drug efficacy.Materials and Methods:Issue of the original 206 cases of lung cancer observed for blood type,cell-based credits,course and effect relationship between stages.Results:More blood supply type CR+PR89% better than that and the less blood supply type.Squamous cell carcinoma and small cell lung cancer CR+PR77% and 79% better than the other cell type.Phase carcinoma and small cell lung cancer CR+PR77% and 79%better than the other cell type.Phase Ⅱ ⅢA and CR+CP period of 80% and 62% better than the period ⅢB and period Ⅳ.Conclusion:By bronchial artery infusion therapy is an effective way to lung cancer,the effect depends on the tumer blood supply,tissue type and course of disease stages.更多还原